title: Gradual filling up of TB drug pipeline: how can we play our role better?
authors.forename: Lalit
authors.initials: L
authors.lastname: Kant
mesh_terms: D000995:Antitubercular Agents / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D003140:Communicable Disease Control / Q000639:trends; D023801:Directly Observed Therapy; D055808:Drug Discovery / Q000639:trends*; D024881:Drug Resistance, Bacterial; D006301:Health Services Needs and Demand / Q000639:trends*; D006801:Humans; D007194:India / Q000453:epidemiology; D009169:Mycobacterium tuberculosis; D009313:National Health Programs; D012107:Research Design; D016896:Treatment Outcome; D014376:Tuberculosis / Q000188:drug therapy* / Q000453:epidemiology / Q000382:microbiology
chemical_list: D000995:Antitubercular Agents